Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes

The partial remission (PR) phase, a period experienced by most patients with type 1 diabetes (T1D) soon after diagnosis, is characterized by low insulin requirements and improved glycemic control. Given the great potential of this phase as a therapeutic window for immunotherapies because of its asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez-Muñoz, Laia, Perna-Barrull, David, Caroz-Armayones, Josep M., Murillo, Marta, Rodriguez-Fernandez, Silvia, Valls, Aina, Vazquez, Federico, Perez, Jacobo, Corripio, Raquel, Castaño, Luis, Bel, Joan, Vives-Pi, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904370/
https://www.ncbi.nlm.nih.gov/pubmed/35280980
http://dx.doi.org/10.3389/fimmu.2022.825426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904370/
https://www.ncbi.nlm.nih.gov/pubmed/35280980
http://dx.doi.org/10.3389/fimmu.2022.825426

Ejemplares similares